Filing Details
- Accession Number:
- 0001209191-21-016886
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 16:37:25
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 16:37:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
718937 | Staar Surgical Co | STAA | Ophthalmic Goods (3851) | 953797439 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1781825 | K. Jon Hayashida | 25651 Atlantic Ocean Drive Lake Forest CA 92630 | Vp, Global Clinical, Medical | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-01 | 16,000 | $35.98 | 26,794 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-01 | 16,000 | $105.43 | 10,794 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Options | Disposition | 2021-03-01 | 16,000 | $0.00 | 16,000 | $35.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,026 | 2020-03-14 | 2029-03-13 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.86 to $106.19, inclusive.
- The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2023.